New York, NYNCT06961630Now EnrollingIRB Ready

Myocardial Injury After Noncardiac Surgery Clinical Trial in New York, NY

Access cutting-edge myocardial injury after noncardiac surgery treatment through this early phase 1 clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by NYU Langone Health

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access myocardial injury after noncardiac surgery specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related myocardial injury after noncardiac surgery treatment provided free

Apply for This New York Location

Check if you qualify for this myocardial injury after noncardiac surgery clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Myocardial Injury After Noncardiac Surgery Study in New York

The goal of this pilot study is to assess enrollment feasibility of a randomized trial of direct oral anticoagulant and high-intensity statin therapy versus usual care in patients with Myocardial Injury after Noncardiac Surgery (MINS). The primary aims of this study are to assess feasibility, study drug adherence, and optimize study design (entry criteria, study endpoints, sample size calculation, site selection) and recruitment strategies for the future multicenter randomized clinical trial studying biomarker-based care in post-operative patients at elevated cardiovascular (CV) risk.

Sponsor: NYU Langone Health

Who Can Participate

Inclusion Criteria

Adults ≥45 years
Underwent major non-cardiac surgery requiring ≥1 overnight inpatient stay in the prior 14 days
Myocardial injury after noncardiac surgery, defined as a post-operative troponin ≥ 99th percentile upper reference limit \[URL\], with rise/fall \>20% indicative of acute myocardial injury.
Ability to provide informed consent

Exclusion Criteria

Expected survival \<6 months
Hemorrhagic disorder
Surgeon feels it is unsafe to initiate low-dose anticoagulation within 14 days of surgery
Indication for oral anticoagulation at discharge
Indication for dual antiplatelet therapy at discharge
Patient already receiving or planned to receive moderate or high-intensity statin
Contraindication to high-intensity statin
Contraindication to rivaroxaban
End stage kidney disease on hemodialysis
Acute liver failure or decompensated cirrhosis

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06961630) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Myocardial Injury After Noncardiac Surgery Treatment Options in New York, NY

If you're searching for myocardial injury after noncardiac surgery treatment options in New York, NY, this clinical trial (NCT06961630) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced myocardial injury after noncardiac surgery specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all myocardial injury after noncardiac surgery clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in New York, NY

See all atrial fibrillation clinical trials recruiting in New York — not just this study.

Browse Atrial Fibrillation Trials in New York →

Browse More Trials by Condition

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY